MCM
MRK icon

Moore Capital Management’s Merck MRK Stock Holding History

Moore Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,074
Closed -$3.41M – 698
2025
Q2 		$3.41M Sell
43,074
-85,493
-66% -$6.8M 0.04% 268
2025
Q1 		$11.5M Buy
+128,567
New +$12M 0.24% 88
2024
Q1 		– Sell
-140,000
Closed -$15.3M – 501
2023
Q4 		$15.3M Buy
140,000
+115,000
+460% +$11.9M 0.26% 70
2023
Q3 		$2.57M Sell
25,000
-45,000
-64% -$4.85M 0.05% 234
2023
Q2 		$8.08M Buy
70,000
+50,000
+250% +$5.68M 0.14% 119
2023
Q1 		$2.13M Buy
+20,000
New +$2.16M 0.04% 241
2014
Q1 		– Sell
-10,480
Closed -$501K – 509
2013
Q4 		$501K Buy
+10,480
New +$479K 0.01% 350

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moore Capital Management's MRK Position: Q3 2025 in Review

Moore Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 43,074 shares — an estimated $3.41M sold.

Moore Capital Management first reported a position in MRK in Q4 2013 and held it in 7 quarters. The position peaked at $15.3M in Q4 2023. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Moore Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Moore Capital Management sold 43,074 Merck shares in Q3 2025, an estimated $3.41M.
  • Moore Capital Management first reported a position in Merck in Q4 2013 and held it in 7 quarters.
  • Moore Capital Management's Merck position peaked at $15.3M in Q4 2023.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Moore Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.